Hyperlipidemia in glycogen storage disease type III: Effect of age and metabolic control

Journal of Inherited Metabolic Disease

Volumn 31, Issue 6, 2008, Pages 729-732

  Bernier, A V ^a   Sentner, C P ^b   Correia, C E ^a   Theriaque, D W ^c   Shuster, J J ^c   Smit, G P A ^b   Weinstein, D A ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GLYCOGEN STORAGE DISEASE TYPE 3; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; INFANT; METABOLIC REGULATION; PREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; BIOPSY; CHILD; CHILD, PRESCHOOL; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; HYPERLIPIDEMIAS; INFANT; INFANT, NEWBORN; RISK FACTORS;

EID: 57649225514     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0919-5     Document Type: Article

References (8)

1. Bandsma RH, Prinsen BH, van der Velden MD, et al (2008) Increased de novo lipogenesis and delayed conversion of large VLDL into IDL particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res [Epub ahead of print] PMID: 18277936.
2. Geberhiwot T, Alger S, McKiernan P, et al (2007) Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. J Inherit Metab Dis 30(3): 406. doi: 10.1007/ s10545-007-0485-2.
3. Hershkovitz E, Donald A, Mullen M, et al (1999) Blood lipids and endothelial function in glycogen storage disease type III. J Inherit Metab Dis 22(8): 891-898. doi: 10.1023/A:1005687323096.
4. Muhlhausen C, Schneppenheim R, Budde U (2005) Decreased plasma concentration of von Willebrand factor antigen (vWF:Ag) in patients with glycogen storage disease type 1a. J Inherit Metab Dis 28: 945-950. doi: 10.1007/s10545-005-0184-9.
5. Nguyen AD, Pan CJ, Weinstein DA (2006) Increased scavenger receptor class B type 1-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type 1a patients. Mol Genet Metab 89(3): 233-238. doi: 10.1016/j.ymgme.2006.05.002.
6. Ubels FL, Rake JP, Slaets JP (2002) Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr 161: S62-s64.
7. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschutter A (2002) Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 33(1): 103-110. doi: 10.1016/S0891-5849(02)00863-8.
8. Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4(1): 95-102. doi: 10.1023/A:1021831621210.